{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T00:22:46Z","timestamp":1709943766289},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,8]]},"DOI":"10.7759\/cureus.55766","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T08:24:31Z","timestamp":1709886271000},"source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of Enfortumab Vedotin After Chemotherapy With Anti-programmed Death-Ligand 1 (PD-L1) Maintenance Treatment in a Clear Cell Variant of Invasive Urothelial Carcinoma of the Renal Pelvis: A Case Report"],"prefix":"10.7759","author":[{"given":"Hiroshi","family":"Hirata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinobu","family":"Hoshii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toyonori","family":"Tsuzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2010.03.142","article-title":"Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract","volume":"184","author":"Margulis V","year":"2010","unstructured":"Margulis V, Youssef RF, Karakiewicz PI, et al.. Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract. J Urol. 2010, 184:453-8. 10.1016\/j.juro.2010.03.142","journal-title":"J Urol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-016-1928-x","article-title":"Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)","volume":"35","author":"Soria F","year":"2017","unstructured":"Soria F, Shariat SF, Lerner SP, et al.. Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC). World J Urol. 2017, 35:379-87. 10.1007\/s00345-016-1928-x","journal-title":"World J Urol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2020.11.005","article-title":"Incidence and survival rates of contemporary patients with invasive upper tract urothelial carcinoma","volume":"4","author":"Coll\u00e0 Ruvolo C","year":"2021","unstructured":"Coll\u00e0 Ruvolo C, Nocera L, Stolzenbach LF, et al.. Incidence and survival rates of contemporary patients with invasive upper tract urothelial carcinoma. Eur Urol Oncol. 2021, 4:792-801. 10.1016\/j.euo.2020.11.005","journal-title":"Eur Urol Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-014-0721-3","article-title":"Impact of variant histology on disease aggressiveness and outcome after nephroureterectomy in Japanese patients with upper tract urothelial carcinoma","volume":"20","author":"Sakano S","year":"2015","unstructured":"Sakano S, Matsuyama H, Kamiryo Y, et al.. Impact of variant histology on disease aggressiveness and outcome after nephroureterectomy in Japanese patients with upper tract urothelial carcinoma. Int J Clin Oncol. 2015, 20:362-8. 10.1007\/s10147-014-0721-3","journal-title":"Int J Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathol.2020.09.004","article-title":"Urothelial carcinoma: variant histology, molecular subtyping, and immunophenotyping significant for treatment outcomes","volume":"53","author":"Takahara T","year":"2021","unstructured":"Takahara T, Murase Y, Tsuzuki T. Urothelial carcinoma: variant histology, molecular subtyping, and immunophenotyping significant for treatment outcomes. Pathology. 2021, 53:56-66. 10.1016\/j.pathol.2020.09.004","journal-title":"Pathology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000000523","article-title":"Prognostic value of variant histology in upper tract urothelial carcinoma treated with nephroureterectomy: a systematic review and meta-analysis","volume":"203","author":"Mori K","year":"2020","unstructured":"Mori K, Janisch F, Parizi MK, et al.. Prognostic value of variant histology in upper tract urothelial carcinoma treated with nephroureterectomy: a systematic review and meta-analysis. J Urol. 2020, 203:1075-84. 10.1097\/JU.0000000000000523","journal-title":"J Urol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.17305\/bjbms.2019.4182","article-title":"Clear cell urothelial carcinoma of the urinary bladder-a rare pathological entity. A case report and a systematic review of the literature","volume":"19","author":"Mihai I","year":"2019","unstructured":"Mihai I, Taban S, Cumpanas A, Olteanu EG, Iacob M, Dema A. Clear cell urothelial carcinoma of the urinary bladder-a rare pathological entity. A case report and a systematic review of the literature. Bosn J Basic Med Sci. 2019, 19:400-3. 10.17305\/bjbms.2019.4182","journal-title":"Bosn J Basic Med Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-2197.1997.tb07625.x","article-title":"Clear-cell transitional cell carcinoma","volume":"67","author":"Braslis KG","year":"1997","unstructured":"Braslis KG, Jones A, Murphy D. Clear-cell transitional cell carcinoma. Aust N Z J Surg. 1997, 67:906-8. 10.1111\/j.1445-2197.1997.tb07625.x","journal-title":"Aust N Z J Surg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.5980\/jpnjurol1989.97.607","article-title":"Primary clear cell carcinoma of the ureter: a case report","volume":"97","author":"Yamashita R","year":"2006","unstructured":"Yamashita R, Yamaguchi R, Yuen K, Niwakawa M, Tobisu K. Primary clear cell carcinoma of the ureter: a case report. Nihon Hinyokika Gakkai Zasshi. 2006, 97:607-9. 10.5980\/jpnjurol1989.97.607","journal-title":"Nihon Hinyokika Gakkai Zasshi"},{"key":"ref10","article-title":"Clear cell variant of invasive urothelial carcinoma of the ureter: a case report","volume":"61","author":"Moriyama H","year":"2015","unstructured":"Moriyama H, Yonehara S, Yoshino T. Clear cell variant of invasive urothelial carcinoma of the ureter: a case report. Hinyokika. 2015, 61:241-4.","journal-title":"Hinyokika"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.14989\/ActaUrolJap_67_7_313","article-title":"Clear cell variant of invasive urothelial carcinoma of the renal pelvis: a case report","volume":"67","author":"Ishibashi Y","year":"2021","unstructured":"Ishibashi Y, Yamaguchi K, Hayashi Y, Onuki T, Suzuki K. Clear cell variant of invasive urothelial carcinoma of the renal pelvis: a case report. Hinyokika Kiyo. 2021, 67:313-6. 10.14989\/ActaUrolJap_67_7_313","journal-title":"Hinyokika Kiyo"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/229053-efficacy-of-enfortumab-vedotin-after-chemotherapy-with-anti-programmed-death-ligand-1-pd-l1-maintenance-treatment-in-a-clear-cell-variant-of-invasive-urothelial-carcinoma-of-the-renal-pelvis-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T08:24:37Z","timestamp":1709886277000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/229053-efficacy-of-enfortumab-vedotin-after-chemotherapy-with-anti-programmed-death-ligand-1-pd-l1-maintenance-treatment-in-a-clear-cell-variant-of-invasive-urothelial-carcinoma-of-the-renal-pelvis-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,8]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.55766","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,8]]}}}